Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design and Setting
2.2. Data Collection
2.3. Survey Questionnaire
2.4. Statistical Analysis
3. Results
3.1. Descriptive Statistics
3.2. Exposure to Misinformation on COVID-19 Vaccination
3.3. Risk Perception about COVID-19
3.4. Attitudes toward the Vaccination Programme
3.5. Public Confidence in Government and Willingness to Get Vaccinated
3.6. Ordinary Regression Analysis
4. Discussion
5. Limitations
6. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Ministry of Health Malaysia. Clinical Guidelines on COVID-19 Vaccination in Malaysia, 4th ed. Available online: https://covid-19.moh.gov.my/garis-panduan/garis-panduan-kkm/ANNEX_48_CLINICAL_GUIDELINES_FOR_COVID_IN_MALAYSIA_4th_EDITION_19102021_FINALE.pdf (accessed on 1 October 2022).
- Dror, A.A.; Eisenbach, N.; Taiber, S.; Morozov, N.G.; Mizrachi, M.; Zigron, A.; Srouji, S.; Sela, E. Vaccine hesitancy: The next challenge in the fight against COVID-19. Eur. J. Epidemiol. 2020, 35, 775–779. [Google Scholar] [CrossRef] [PubMed]
- Danabal, K.G.M.; Magesh, S.S.; Saravanan, S.; Gopichandran, V. Attitude towards COVID-19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India—A community based survey. BMC Health Serv. Res. 2021, 21, 994. [Google Scholar] [CrossRef] [PubMed]
- Cordina, M.; Lauri, M.A.; Lauri, J. Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine. Pharm. Pract. 2021, 19, 2317. [Google Scholar] [CrossRef] [PubMed]
- Paul, E.; Steptoe, A.; Fancourt, D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg. Health Eur. 2021, 1, 100012. [Google Scholar] [CrossRef]
- Iguacel, I.; Maldonado, A.L.; Ruiz-Cabello, A.L.; Samatán, E.; Alarcón, J.; Orte, M.; Mateos, S.S.; Martínez-Jarreta, B. Attitudes of Healthcare Professionals and General Population Toward Vaccines and the Intention to Be Vaccinated Against COVID-19 in Spain. Front. Public Health 2021, 9, 739003. [Google Scholar] [CrossRef]
- Tahir, M.J.; Saqlain, M.; Tariq, W.; Waheed, S.; Tan, S.H.S.; Nasir, S.I.; Ullah, I.; Ahmed, A. Population preferences and attitudes towards COVID-19 vaccination: A cross-sectional study from Pakistan. BMC Public Health 2021, 21, 1759. [Google Scholar] [CrossRef]
- Suarez-Lledo, V.; Alvarez-Galvez, J. Prevalence of health misinformation on social media: Systematic review. J. Med. Internet Res. 2021, 23, e17187. [Google Scholar] [CrossRef]
- Panahi, S.; Ghalavand, H.; Sedghi, S. Opportunities and challenges of social media for health knowledge management: A narrative review. J. Educ. Health Promot. 2020, 9, 144. [Google Scholar] [CrossRef]
- Kim, H.K.; Tandoc, E.C.J. Consequences of online misinformation on COVID-19: Two potential pathways and disparity by eHealth literacy. Front. Psychol. 2022, 13, 783909. [Google Scholar] [CrossRef]
- Barua, Z.; Barua, S.; Aktar, S.; Kabir, N.; Li, M. Effects of misinformation on COVID-19 individual responses and recommendations for resilience of disastrous consequences of misinformation. Prog. Disaster Sci. 2020, 8, 100119. [Google Scholar] [CrossRef]
- Nelson, T.; Kagan, N.; Critchlow, C.; Hillard, A.; Hsu, A. The danger of misinformation in the COVID-19 crisis. Mo. Med. 2020, 117, 510–512. [Google Scholar] [PubMed]
- Organisation for Economic Co-operation and Development, OECD. Transparency, Communication and Trust: The Role of Public Communication in Responding to the Wave of Disinformation about the New Coronavirus. Tackling Coronavirus (COVID-19). 2020, pp. 1–12. Available online: https://www-oecd-org.proxy.library.uu.nl/coronavirus/policy-responses/transparency-communication-and-trust-bef7ad6e/#figure-d1e97%0Ahttps://read.oecd-ilibrary.org/view/?ref=135_135220-cvba4lq3ru&title=Transparency-communication-and-trust-The-role-of-publi (accessed on 1 October 2022).
- Han, Q.; Zheng, B.; Cristea, M.; Agostini, M.; Bélanger, J.J.; Gützkow, B.; Kreienkamp, J.; Leander, N.P. PsyCorona Collaboration. Trust in government regarding COVID-19 and its associations with preventive health behaviour and prosocial behaviour during the pandemic: A cross-sectional and longitudinal study. Psychol. Med. 2021, 1–11. [Google Scholar] [CrossRef] [PubMed]
- Schmid, P.; Rauber, D.; Betsch, C.; Lidolt, G.; Denker, M.-L. Barriers of Influenza Vaccination Intention and Behavior—A Systematic Review of Influenza Vaccine Hesitancy, 2005–2016. PLoS ONE 2017, 12, e0170550. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Palamenghi, L.; Barello, S.; Boccia, S.; Graffigna, G. Mistrust in biomedical research and vaccine hesitancy: The forefront challenge in the battle against COVID-19 in Italy. Eur. J. Epidemiol. 2020, 35, 785–788. [Google Scholar] [CrossRef]
- Simione, L.; Vagni, M.; Gnagnarella, C.; Bersani, G.; Pajardi, D. Mistrust and beliefs in conspiracy theories differently mediate the effects of psychological factors on propensity for COVID-19 vaccine. Front. Psychol. 2021, 12, 683684. [Google Scholar] [CrossRef]
- Rani, M.D.M.; Mohamed, N.A.; Solehan, H.M.; Ithnin, M.; Ariffien, A.R.; Isahak, I. Assessment of acceptability of the COVID-19 vaccine based on the health belief model among Malaysians-A qualitative approach. PLoS ONE 2022, 17, e0269059. [Google Scholar] [CrossRef]
- Du, M.; Tao, L.; Liu, J. The association between risk perception and COVID-19 vaccine hesitancy for children among reproductive women in China: An online survey. Front. Med. 2021, 8, 741298. [Google Scholar] [CrossRef]
- Bhuiya, T.; Iii, R.K.; Conte, M.A.; Cervia, J.S. Predictors of misperceptions, risk perceptions, and personal risk perceptions about COVID-19 by country, education and income. J. Investig. Med. 2021, 69, 1473–1478. [Google Scholar] [CrossRef]
- Solís Arce, J.S.; Warren, S.S.; Meriggi, N.F.; Scacco, A.; McMurry, N.; Voors, M.; Syunyaev, G.; Malik, A.A.; Aboutajdine, S.; Adeojo, O.; et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat. Med. 2021, 27, 1385–1394. [Google Scholar] [CrossRef]
- Wagner, A.L.; Masters, N.B.; Domek, G.J.; Mathew, J.L.; Sun, X.; Asturias, E.J.; Ren, J.; Huang, Z.; Contreras-Roldan, I.L.; Gebremeskel, B.; et al. Comparisons of vaccine hesitancy across five low- and middle-income countries. Vaccines 2019, 7, 155. [Google Scholar] [CrossRef]
- Pek, C.K.; Choy, K.Y.; Toh, K.K.; Foo, F.E.; Cham, T.H. Dataset of vaccination and confidence in the Malaysian government during COVID-19 pandemic. Data Brief 2022, 42, 108148. [Google Scholar] [CrossRef] [PubMed]
- Jafar, A.; Dambul, R.; Dollah, R.; Sakke, N.; Mapa, M.T.; Joko, E.P. COVID-19 vaccine hesitancy in Malaysia: Exploring factors and identifying highly vulnerable groups. PLoS ONE 2022, 17, e0270868. [Google Scholar] [CrossRef] [PubMed]
- Ruhi, S.; Nabilah, P.; Attalla, S.M.; Treki, M.; Khan, J.; Ishaka, A.; Baber, S.; Kaleemullah, M.; Hasan, S. Understanding the negative public perception on vaccination in west coast and east coast peninsular Malaysia. Malays. J. Med. Health Sci. 2021, 17, 77–82. [Google Scholar]
- Napolitano, F.; D’Alessandro, A.; Angelillo, I.F. Investigating Italian parents’ vaccine hesitancy: A cross-sectional survey. Hum. Vaccines Immunother. 2018, 14, 1558–1565. [Google Scholar] [CrossRef] [Green Version]
- Phillips, R.; Gillespie, D.; Hallingberg, B.; Evans, J.; Taiyari, K.; Torrens-Burton, A.; Cannings-John, R.; Williams, D.; Sheils, E.; Ashfield-Watt, P.; et al. Perceived threat of COVID-19, attitudes towards vaccination, and vaccine hesitancy: A prospective longitudinal study in the UK. Br. J. Health Psychol. 2022, 27, 1354–1381. [Google Scholar] [CrossRef]
- Conroy, R. Sample size: A rough guide. Ethics (Medical Research) Committee. 2015. Available online: http://www.beaumontethics.ie/docs/application/samplesizecalculation.pdf (accessed on 1 October 2022).
- Israel, G.D. Determining Sample Size; Report No.: Fact Sheet PEOD-6; University of Florida: Gainesville, FL, USA, 1992. [Google Scholar]
- Malaysian Communications and Multimedia Commission. Internet Users Survey 2018: Statistical Brief Number Twenty-Three. Cyberjaya: MCMC. 2018. Available online: https://www.mcmc.gov.my/skmmgovmy/media/General/pdf/Internet-Users-Survey-2018.pdf (accessed on 10 May 2020).
- Brislin, R.W. Back-translation for cross-cultural research. J. Cross-Cult. Psychol. 1970, 3, 185–216. [Google Scholar] [CrossRef]
- Kim, H.K.; Ahn, J.; Atkinson, L.; Kahlor, L.A. Effects of COVID-19 misinformation on information seeking, avoidance, and processing: A multicountry comparative study. Sci. Commun. 2020, 42, 586–615. [Google Scholar] [CrossRef]
- Oh, S.-H.; Paek, H.-J.; Hove, T. Cognitive and emotional dimensions of perceived risk characteristics, genre-specific media effects, and risk perceptions: The case of H1N1 influenza in South Korea. Asian J. Commun. 2015, 25, 14–32. [Google Scholar] [CrossRef]
- Han, G.; Zhang, J.; Chu, K.; Shen, G. Self-other differences in H1N1 flu risk perception in a global context: A comparative study between the United States and China. Health Commun. 2014, 29, 109–123. [Google Scholar] [CrossRef]
- Lee, J.; Kim, J.W.; Chock, T.M. From risk butterflies to citizens engaged in risk prevention in the zika virus crisis: Focusing on personal, societal and global risk perceptions. J. Health Commun. 2020, 25, 671–680. [Google Scholar] [CrossRef]
- Martin, L.R.; Petrie, K.J. Understanding the dimensions of anti-vaccination attitudes: The vaccination attitudes examination (VAX) Scale. Ann. Behav. Med. 2017, 51, 652–660. [Google Scholar] [CrossRef] [PubMed]
- Malik, A.A.; McFadden, S.M.; Elharake, J.; Omer, S.B. Determinants of COVID-19 vaccine acceptance in the US. eClinicalMedicine 2020, 26, 100495. [Google Scholar] [CrossRef] [PubMed]
- van Griethuijsen, R.A.; van Eijck, M.W.; Haste, H.; den Brok, P.J.; Skinner, N.C.; Mansour, N.; Gencer, A.S.; BouJaoude, S. Global patterns in students’ views of science and interest in science. Res. Sci. Educ. 2015, 45, 581–603. [Google Scholar] [CrossRef]
- Teh, H.S.; Woon, Y.L.; Leong, C.T.; Hing, N.Y.L.; Mien, T.Y.S.; Roope, L.S.; Clarke, P.M.; Lim, L.-L.; Buckell, J. Malaysian public preferences and decision making for COVID-19 vaccination: A discrete choice experiment. Lancet Reg. Health West. Pac. 2022, 27, 100534. [Google Scholar] [CrossRef]
- Saied, S.M.; Saied, E.M.; Kabbash, I.A.; Abdo, S.A.E. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J. Med. Virol. 2021, 93, 4280–4291. [Google Scholar] [CrossRef]
- Kreps, S.E.; Goldfarb, J.L.; Brownstein, J.S.; Kriner, D.L. The relationship between US adults’ misconceptions about COVID-19 vaccines and vaccination preferences. Vaccines 2021, 9, 901. [Google Scholar] [CrossRef]
- Neely, S.R.; Eldredge, C.; Ersing, R.; Remington, C. Vaccine hesitancy and exposure to misinformation: A survey analysis. J. Gen. Intern. Med. 2022, 37, 179–187. [Google Scholar] [CrossRef]
- Neumann-Böhme, S.; Varghese, N.E.; Sabat, I.; Barros, P.P.; Brouwer, W.; Van Exel, J.; Schreyögg, J.; Stargardt, T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur. J. Health Econ. 2020, 21, 977–982. [Google Scholar] [CrossRef]
- Fadda, M.; Albanese, E.; Suggs, L.S. When a COVID-19 vaccine is ready, will we all be ready for it? Int. J. Public Health 2020, 65, 711–712. [Google Scholar] [CrossRef]
- Kashte, S.; Gulbake, A.; El-Amin, S.F., III; Gupta, A. COVID-19 vaccines: Rapid development, implications, challenges and future prospects. Hum. Cell 2021, 34, 711–733. [Google Scholar] [CrossRef]
- Piltch-Loeb, R.; Harriman, N.W.; Healey, J.; Bonetti, M.; Toffolutti, V.; Testa, M.A.; Su, M.; Savoia, E. COVID-19 vaccine concerns about safety, effectiveness, and policies in the United States, Canada, Sweden, and Italy among unvaccinated individuals. Vaccines 2021, 9, 1138. [Google Scholar] [CrossRef] [PubMed]
- Al-Qerem, W.A.; Jarab, A.S. COVID-19 vaccination acceptance and its associated factors among a middle eastern population. Front. Public Health 2021, 9, 632914. [Google Scholar] [CrossRef]
- Tu, P.; Kotarba, M.; Bier, B.; Clark, R.; Lin, C. Internal and external motivations and risk perception toward COVID-19 vaccination in adolescents in the U.S. Vaccines 2022, 10, 697. [Google Scholar] [CrossRef] [PubMed]
- Bono, S.A.; Siau, C.S.; Chen, W.S.; Low, W.Y.; Villela, E.F.D.M.; Pengpid, S.; Hasan, M.T.; Sessou, P.; Ditekemena, J.D.; Amodan, B.O.; et al. Adults’ acceptance of COVID-19 vaccine for children in selected lower- and middle-income countries. Vaccines 2022, 10, 11. [Google Scholar] [CrossRef] [PubMed]
- Azlan, A.A.; Hamzah, M.R.; Sern, T.J.; Ayub, S.H.; Mohamad, E. Public knowledge, attitudes and practices towards COVID-19: A cross-sectional study in Malaysia. PLoS ONE 2020, 15, e0233668. [Google Scholar] [CrossRef]
- Lqbal MT, B.M.; Imran SA, M.; Tye, G.J.; Zaman, W.K.; Nordin, F. COVID-19 vaccination effectiveness: A review in early vaccine adopters in Asian Countries. Eur. Rev. Med. Pharmacol. Sci. 2022, 26, 4902–4925. [Google Scholar]
- Sato, R. COVID-19 vaccine hesitancy and trust in government in Nigeria. Vaccines 2022, 10, 1008. [Google Scholar] [CrossRef]
- Cooper, S.; van Rooyen, H.; Wiysonge, C.S. COVID-19 vaccine hesitancy in South Africa: How can we maximize uptake of COVID-19 vaccines? Expert Rev. Vaccines 2021, 20, 921–933. [Google Scholar] [CrossRef]
- Griva, K.; Tan, K.Y.K.; Chan, F.H.F.; Periakaruppan, R.; Ong, B.W.L.; Soh, A.S.E.; Chen, M.I. Evaluating rates and determinants of COVID-19 vaccine hesitancy for adults and children in the Singapore population: Strengthening our community’s resilience against threats from emerging infections (SOCRATEs) cohort. Vaccines 2021, 9, 1415. [Google Scholar] [CrossRef]
- Mueangpoon, K.; Inchan, C.; Kaewmuneechoke, P.; Rattana, P.; Budsratid, S.; Japakiya, S.; Ngamchaliew, P.; Vichitkunakorn, P. Self-reported COVID-19 vaccine hesitancy and willingness to pay: A cross-sectional survey in Thailand. Vaccines 2022, 10, 627. [Google Scholar] [CrossRef]
- Yanto, T.A.; Octavius, G.S.; Heriyanto, R.S.; Ienawi, C.; Nisa, H.; Pasai, H.E. Psychological factors affecting COVID-19 vaccine acceptance in Indonesia. Egypt. J. Neurol. Psychiatry Neurosurg. 2021, 57, 177. [Google Scholar] [CrossRef] [PubMed]
- Kukreti, S.; Rifai, A.; Padmalatha, S.; Lin, C.Y.; Yu, T.; Ko, W.C.; Chen, P.-L.; Strong, C.; Ko, N.-Y. Willingness to obtain COVID-19 vaccination in general population: A systematic review and meta-analysis. J. Glob. Health 2022, 12, 05006. [Google Scholar] [CrossRef]
- Khattak, S.; Idrees, M.; Iqbal, H.I.; Khan, M.; Assad, N.; Khan, M.N.; Yousaf, M.T.; Farooq, M.; Yang, C.-Y.; Wu, D.-D.; et al. Assessment of attitudes and intentions towards COVID-19 vaccines and associated factors among general populations of Pakistan: A cross-sectional study. Vaccines 2022, 10, 1583. [Google Scholar] [CrossRef]
- Callaghan, T.; Moghtaderi, A.; Lueck, J.A.; Hotez, P.; Strych, U.; Dor, A.; Fowler, E.F.; Motta, M. Correlates and disparities of intention to vaccinate against COVID-19. Soc. Sci. Med. 2021, 272, 113638. [Google Scholar] [CrossRef]
- Reuters. False Claim: A COVID-19 Vaccine will Genetically Modify Humans. 2020. Available online: https://www.reuters.com/article/uk-factcheck-covid-19-vaccine-modify-idUSKBN22U2BZ (accessed on 13 December 2020).
- Gagneux-Brunon, A.; Detoc, M.; Bruel, S.; Tardy, B.; Rozaire, O.; Frappe, P.; Botelho-Nevers, E. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: A cross-sectional survey. J. Hosp. Infect. 2021, 108, 168–173. [Google Scholar] [CrossRef]
- Shekhar, R.; Sheikh, A.; Upadhyay, S.; Singh, M.; Kottewar, S.; Mir, H.; Barrett, E.; Pal, S. COVID-19 Vaccine Acceptance among Health Care Workers in the United States. Vaccines 2021, 9, 119. [Google Scholar] [CrossRef]
- Nailul Muna, A.M.; Khalid, K.; Siti Noriani, A.W.; Irma Liyana, M.; Siti Zulaiha, C.H.; Mohamad Zamri, K.; Othman, W. COVID-19 vaccine hesitancy: Mobile education initiatives to improve vaccination uptake among healthcare workers. Med. Health 2022, 17, 260–266. [Google Scholar]
- Sri, A.H. Public awareness, knowledge, and attitude towards conventional and modern biotechnology based vaccines in Malaysia. J. Pengaj. Umum Asia Tenggara 2021, 22, 198–214. [Google Scholar]
- Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021, 27, 225–228. [Google Scholar] [CrossRef]
- Hawlader, M.D.H.; Rahman, M.L.; Nazir, A.; Ara, T.; Haque, M.M.A.; Saha, S.; Barsha, S.Y.; Hossian, M.; Matin, K.F.; Siddiquea, S.R.; et al. COVID-19 vaccine acceptance in South Asia: A multi-country study. Int. J. Infect. Dis. 2021, 114, 1–10. [Google Scholar] [CrossRef]
- Sallam, M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef] [PubMed]
Total | ||
---|---|---|
n | % | |
Socio-demographic: | ||
Gender | ||
Female | 536 | 69.2 |
Male | 239 | 30.8 |
Age | 33.71 ± 10.71 (18–75) a | |
Ethnicity | ||
Malay | 523 | 67.5 |
Chinese | 167 | 21.5 |
Indian | 20 | 2.6 |
Bumiputera (Sabah/Sarawak) | 59 | 7.6 |
Others | 6 | 0.8 |
Locality | ||
Urban | 503 | 64.9 |
Rural | 272 | 35.1 |
State | ||
Johor | 60 | 7.7 |
Kedah | 41 | 5.3 |
Kelantan | 29 | 3.7 |
Melaka | 19 | 2.5 |
Negeri Sembilan | 44 | 5.7 |
Pahang | 31 | 4.0 |
Perak | 43 | 5.5 |
Perlis | 6 | 0.8 |
Pulau Pinang | 22 | 2.8 |
Terengganu | 27 | 3.5 |
Sabah | 30 | 3.9 |
Sarawak | 41 | 5.3 |
Selangor | 281 | 36.3 |
Federal Territory of Kuala Lumpur | 87 | 11.2 |
Federal Territory of Putrajaya | 1 | 0.1 |
Federal Territory of Labuan | 13 | 1.7 |
Employment status | ||
Government employee | 147 | 19.0 |
Private employee | 364 | 47.0 |
Self-employed (registered) | 35 | 4.5 |
Self-employed (not registered) | 29 | 3.7 |
Unpaid family worker | 4 | 0.5 |
Not employed | 196 | 25.3 |
Income | ||
Under MYR 4360 per month (including no income) | 416 | 53.7 |
MYR 4361–9620 per month | 210 | 27.1 |
Above MYR 9621 per month | 149 | 19.2 |
Health status | ||
Very bad | 10 | 1.3 |
Bad | 14 | 1.8 |
Average | 96 | 12.4 |
Good | 381 | 49.2 |
Very good | 274 | 35.4 |
Health problem | ||
Yes, more than one disease | 39 | 5.0 |
Yes, only one disease | 106 | 13.7 |
No diseases | 630 | 81.3 |
Source of Information | Frequency | Percentage |
---|---|---|
Government organisations | 255 | 32.9 |
Newspaper or online newspapers | 231 | 29.8 |
Doctor or healthcare provider | 108 | 13.9 |
Brochures, pamphlets, etc. | 62 | 8.0 |
Other | 48 | 6.2 |
Friends/co-workers | 34 | 4.4 |
Family | 33 | 4.3 |
Alternative medicine practitioner | 4 | 0.5 |
Media | Percentage | |
---|---|---|
Yes | No | |
Online news portal | 69.0 | 31.0 |
68.0 | 32.0 | |
Television | 64.4 | 35.6 |
51.5 | 48.5 | |
39.5 | 60.5 | |
Telegram | 32.5 | 67.5 |
31.6 | 68.4 | |
Radio | 29.4 | 70.6 |
YouTube | 25.8 | 74.2 |
Total | ||
---|---|---|
n | % | |
COVID-19 vaccines affect human DNA. | ||
Not at all | 464 | 59.9 |
Rarely | 181 | 23.4 |
Occasionally | 88 | 11.4 |
Very frequently | 42 | 5.4 |
COVID-19 vaccines contain pig fat. | ||
Not at all | 472 | 60.9 |
Rarely | 181 | 23.4 |
Occasionally | 78 | 10.1 |
Very frequently | 44 | 5.7 |
A nurse fainted after she received the COVID-19 vaccine. | ||
Not at all | 326 | 42.1 |
Rarely | 305 | 39.4 |
Occasionally | 106 | 13.7 |
Very frequently | 38 | 4.9 |
COVID-19 vaccines contain live viruses that can make people sick with COVID-19. | ||
Not at all | 413 | 53.3 |
Rarely | 213 | 27.5 |
Occasionally | 107 | 13.8 |
Very frequently | 42 | 5.4 |
Those who have recovered from COVID-19 do not need to get vaccinated. | ||
Not at all | 458 | 59.1 |
Rarely | 171 | 22.1 |
Occasionally | 97 | 12.5 |
Very frequently | 49 | 6.3 |
Vaccines for COVID-19 have a microchip that can track the location of the patient. | ||
Not at all | 465 | 60.0 |
Rarely | 129 | 16.6 |
Occasionally | 79 | 10.2 |
Very frequently | 102 | 13.2 |
The COVID-19 vaccines are not safe because they were developed rapidly. | ||
Not at all | 293 | 37.8 |
Rarely | 198 | 25.5 |
Occasionally | 135 | 17.4 |
Very frequently | 149 | 19.2 |
The COVID-19 vaccine causes serious side effects like allergic reactions. | ||
Not at all | 136 | 17.5 |
Rarely | 296 | 38.2 |
Occasionally | 185 | 23.9 |
Very frequently | 158 | 20.4 |
The COVID-19 vaccine can cause infertility in women. | ||
Not at all | 496 | 64.0 |
Rarely | 202 | 26.1 |
Occasionally | 55 | 7.1 |
Very frequently | 22 | 2.8 |
Once you receive the COVID-19 vaccine, you will not have to wear a mask or practice social-distancing. | ||
Not at all | 446 | 57.5 |
Rarely | 153 | 19.7 |
Occasionally | 84 | 10.8 |
Very frequently | 92 | 11.9 |
Total | ||
---|---|---|
n | % | |
The problem of the COVID-19 pandemic is important to me. | ||
Not at all | 6 | 0.8 |
Slightly | 4 | 0.5 |
Moderately | 18 | 2.3 |
Quite a bit | 65 | 8.4 |
Very much | 237 | 30.6 |
Completely | 445 | 57.4 |
I am worried that I may be infected with COVID-19 in the future. | ||
Not at all | 11 | 1.4 |
Slightly | 16 | 2.1 |
Moderately | 37 | 4.8 |
Quite a bit | 91 | 11.7 |
Very much | 167 | 21.5 |
Completely | 453 | 58.5 |
It is likely that I will be infected with COVID-19. | ||
Not at all | 40 | 5.2 |
Slightly | 98 | 12.6 |
Moderately | 141 | 18.2 |
Quite a bit | 196 | 25.3 |
Very much | 140 | 18.1 |
Completely | 160 | 20.6 |
I have felt at risk of COVID-19 infection. | ||
Not at all | 120 | 15.5 |
Slightly | 92 | 11.9 |
Moderately | 106 | 13.7 |
Quite a bit | 150 | 19.4 |
Very much | 159 | 20.5 |
Completely | 148 | 19.1 |
Total | ||
---|---|---|
n | % | |
Mistrust of vaccine benefits: | ||
I feel safe after being vaccinated. a | ||
Strongly disagree | 27 | 3.5 |
Disagree | 26 | 3.4 |
Slightly disagree | 85 | 11.0 |
Slightly agree | 186 | 24.0 |
Agree | 223 | 28.8 |
Strongly agree | 228 | 29.4 |
I can rely on vaccines to stop serious infectious diseases. a | ||
Strongly disagree | 47 | 6.1 |
Disagree | 53 | 6.8 |
Slightly disagree | 113 | 14.6 |
Slightly agree | 207 | 26.7 |
Agree | 182 | 23.5 |
Strongly agree | 173 | 22.3 |
I feel protected after getting vaccinated. a | ||
Strongly disagree | 22 | 2.8 |
Disagree | 28 | 3.6 |
Slightly disagree | 84 | 10.8 |
Slightly agree | 200 | 25.8 |
Agree | 229 | 29.5 |
Strongly agree | 212 | 27.4 |
Worries about unforeseen future effects: | ||
Although most vaccines appear to be safe, there may be problems that we have not yet discovered. | ||
Strongly disagree | 12 | 1.5 |
Disagree | 25 | 3.2 |
Slightly disagree | 105 | 13.5 |
Slightly agree | 214 | 27.6 |
Agree | 205 | 26.5 |
Strongly agree | 214 | 27.6 |
Vaccines can cause unforeseen problems in children. | ||
Strongly disagree | 64 | 8.3 |
Disagree | 106 | 13.7 |
Slightly disagree | 206 | 26.6 |
Slightly agree | 195 | 25.2 |
Agree | 122 | 15.7 |
Strongly agree | 82 | 10.6 |
I worry about the unknown effects of vaccines in the future. | ||
Strongly disagree | 59 | 7.6 |
Disagree | 102 | 13.2 |
Slightly disagree | 140 | 18.1 |
Slightly agree | 216 | 27.9 |
Agree | 130 | 16.8 |
Strongly agree | 128 | 16.5 |
Concerns about commercial profiteering: | ||
Vaccines make a lot of money for pharmaceutical companies, but do not do much for regular people. | ||
Strongly disagree | 160 | 20.6 |
Disagree | 141 | 18.2 |
Slightly disagree | 193 | 24.9 |
Slightly agree | 143 | 18.5 |
Agree | 67 | 8.6 |
Strongly agree | 71 | 9.2 |
Authorities promote vaccination for financial gain, not for people’s health. | ||
Strongly disagree | 335 | 43.2 |
Disagree | 177 | 22.8 |
Slightly disagree | 119 | 15.4 |
Slightly agree | 92 | 11.9 |
Agree | 28 | 3.6 |
Strongly agree | 24 | 3.1 |
Vaccination programs are a big deception. | ||
Strongly disagree | 457 | 59.0 |
Disagree | 131 | 16.9 |
Slightly disagree | 106 | 13.7 |
Slightly agree | 63 | 8.1 |
Agree | 10 | 1.3 |
Strongly agree | 8 | 1.0 |
Preference for natural immunity: | ||
Natural immunity lasts longer than vaccination. | ||
Strongly disagree | 173 | 22.3 |
Disagree | 149 | 19.2 |
Slightly disagree | 199 | 25.7 |
Slightly agree | 128 | 16.5 |
Agree | 69 | 8.9 |
Strongly agree | 57 | 7.4 |
Natural exposure to viruses and germs gives the safest protection. | ||
Strongly disagree | 272 | 35.1 |
Disagree | 165 | 21.3 |
Slightly disagree | 183 | 23.6 |
Slightly agree | 95 | 12.3 |
Agree | 38 | 4.9 |
Strongly agree | 22 | 2.8 |
Being exposed to diseases naturally is safer for the immune system than being exposed through vaccination. | ||
Strongly disagree | 279 | 36.0 |
Disagree | 173 | 22.3 |
Slightly disagree | 191 | 24.6 |
Slightly agree | 93 | 12.0 |
Agree | 24 | 3.1 |
Strongly agree | 15 | 1.9 |
Total | ||
---|---|---|
n | % | |
I am confident in the Malaysian government’s ability to effectively manage the COVID-19 vaccination program. a | ||
1 (No confidence) | 77 | 10.1 |
2 | 101 | 13.2 |
3 | 162 | 21.1 |
4 | 168 | 21.9 |
5 | 146 | 19.1 |
6 (Very high confidence) | 112 | 14.6 |
I am confident in the ability of the Malaysian public health service to effectively manage the COVID-19 vaccination program. a | ||
1 (No confidence) | 32 | 4.2 |
2 | 61 | 8.0 |
3 | 119 | 15.5 |
4 | 181 | 23.6 |
5 | 203 | 26.5 |
6 (Very high confidence) | 170 | 22.2 |
Total | ||
---|---|---|
n | % | |
If a COVID-19 vaccine is recommended for you, would you take it? a | ||
No | 8 | 1.0 |
Yes | 756 | 99.0 |
Variables | Mistrust of Vaccine Benefits | Worries about Unforeseen Future Effects | Concerns about Commercial Profiteering | Preference for Natural Immunity | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Block 1 | Block 2 | Block 1 | Block 2 | Block 1 | Block 2 | Block 1 | Block 2 | |||||||||
t | t | t | t | t | t | t | t | |||||||||
Male (vs. female) | 0.002 | 0.059 | −0.02 | −0.44 | 0.06 | 1.68 | 0.05 | 1.22 | 0.16 | 4.52 *** | 0.14 | 4.09 *** | 0.09 | 2.44 * | 0.08 | 2.17 * |
Age | 0.23 | 5.38 *** | 0.24 | 5.87 *** | 0.17 | 3.84 *** | 0.19 | 4.45 *** | 0.21 | 5.16 *** | 0.23 | 5.92 *** | 0.22 | 5.16 *** | 0.23 | 5.39 *** |
Ethnicity (vs. other) | ||||||||||||||||
Malay | 0.37 | 1.94 | 0.37 | 2.02 * | 0.57 | 2.98 ** | 0.56 | 2.95 ** | 0.31 | 1.70 | 0.31 | 1.77 | 0.06 | 0.32 | 0.05 | 0.26 |
Chinese | 0.53 | 3.13 ** | 0.47 | 2.87 ** | 0.51 | 2.95 ** | 0.49 | 2.90 ** | 0.53 | 3.23 *** | 0.47 | 3.00 ** | 0.18 | 1.05 | 0.16 | 0.93 |
Indian | 0.18 | 2.40 * | 0.17 | 2.42 * | 0.20 | 2.75 ** | 0.22 | 3.06 ** | 0.15 | 2.14 * | 0.15 | 2.29 * | 0.04 | 0.56 | 0.05 | 0.63 |
Bumiputera Sabah/Sarawak | 0.21 | 1.84 | 0.24 | 2.17 * | 0.32 | 2.78 ** | 0.33 | 2.93 ** | 0.12 | 1.06 | 0.14 | 1.38 | 0.05 | 0.41 | 0.06 | 0.49 |
Income | −0.04 | −0.95 | −0.06 | −1.41 | −0.03 | −0.79 | −0.04 | −1.07 | −0.09 | −2.29 * | −0.11 | −2.91 ** | −0.09 | −2.04 * | −0.09 | −2.22 * |
Rural (vs. urban) | 0.06 | 1.64 | 0.08 | 2.18 * | 0.01 | 0.12 | 0.02 | 0.48 | −0.01 | −0.21 | 0.02 | 0.43 | 0.04 | 1.01 | 0.05 | 1.18 |
Employment (vs. private) | ||||||||||||||||
Government | −0.06 | −1.55 | −0.05 | −1.35 | −0.01 | −0.19 | −0.01 | −0.21 | 0.001 | 0.03 | 0.01 | 0.33 | 0.02 | 0.49 | 0.02 | 0.48 |
Self-employed (registered) | 0.01 | 0.39 | −0.004 | −0.11 | 0.03 | 0.87 | 0.02 | 0.55 | 0.01 | 0.16 | −0.01 | −0.39 | −0.02 | −0.53 | −0.03 | −0.79 |
Self-employed (non-registered) | 0.01 | 0.20 | −0.001 | −0.02 | −0.05 | −1.24 | −0.05 | −1.43 | −0.03 | −0.79 | −0.04 | −1.04 | −0.03 | −0.74 | −0.03 | −0.91 |
Unpaid | −0.03 | −0.03 | −0.03 | −0.81 | −0.04 | −1.13 | −0.05 | −1.36 | −0.02 | −0.53 | −0.02 | −0.64 | −0.01 | −0.34 | −0.02 | −0.44 |
Not employed | 0.06 | 1.57 | 0.04 | 1.19 | 0.01 | 0.18 | 0.01 | 0.29 | 0.01 | 0.17 | −0.01 | −0.18 | 0.00 | −0.01 | −0.003 | −0.07 |
COVID-19 vaccine misinformation exposure | - | - | 0.11 | 3.31 ** | - | - | 0.13 | 3.57 *** | - | - | 0.10 | 2.96 ** | - | - | 0.12 | 3.21 *** |
Perceived risk | - | - | −0.07 | 0.04 * | - | - | 0.10 | 2.81 ** | - | - | 0.003 | 0.08 | - | - | −0.003 | −0.08 |
Confidence in government | - | - | −0.26 | −7.07 *** | - | - | −0.12 | −3.23 *** | - | - | −0.28 | −7.98 *** | - | - | −0.09 | −2.40 * |
Adj R2 = 0.132 ΔR2 = 0.078 F(16, 749) = 8.26 *** | Adj R2 = 0.068 ΔR2 = 0.044 F(16, 749) = 4.48 *** | Adj R2 = 0.197 ΔR2 = 0.082 F(16, 749) = 12.70 *** | Adj R2 = 0.063 ΔR2 = 0.022 F(16, 749) = 4.24 *** |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mohamad, E.; Tham, J.S.; Mohd Ajis, S.Z.; Hamzah, M.R.; Ayub, S.H.; Tri Sakti, A.M.; Azlan, A.A. Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia. Int. J. Environ. Res. Public Health 2022, 19, 14623. https://doi.org/10.3390/ijerph192214623
Mohamad E, Tham JS, Mohd Ajis SZ, Hamzah MR, Ayub SH, Tri Sakti AM, Azlan AA. Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia. International Journal of Environmental Research and Public Health. 2022; 19(22):14623. https://doi.org/10.3390/ijerph192214623
Chicago/Turabian StyleMohamad, Emma, Jen Sern Tham, Siti Zaiton Mohd Ajis, Mohammad Rezal Hamzah, Suffian Hadi Ayub, Andi Muhammad Tri Sakti, and Arina Anis Azlan. 2022. "Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia" International Journal of Environmental Research and Public Health 19, no. 22: 14623. https://doi.org/10.3390/ijerph192214623
APA StyleMohamad, E., Tham, J. S., Mohd Ajis, S. Z., Hamzah, M. R., Ayub, S. H., Tri Sakti, A. M., & Azlan, A. A. (2022). Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia. International Journal of Environmental Research and Public Health, 19(22), 14623. https://doi.org/10.3390/ijerph192214623